BE888209A - Solutions concentrees stables de cisplatine dans un solvant - Google Patents

Solutions concentrees stables de cisplatine dans un solvant

Info

Publication number
BE888209A
BE888209A BE0/204323A BE204323A BE888209A BE 888209 A BE888209 A BE 888209A BE 0/204323 A BE0/204323 A BE 0/204323A BE 204323 A BE204323 A BE 204323A BE 888209 A BE888209 A BE 888209A
Authority
BE
Belgium
Prior art keywords
cisplatin
solvent
concentrated solutions
stable concentrated
stable
Prior art date
Application number
BE0/204323A
Other languages
English (en)
Inventor
M Kaplan
A Granatek
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of BE888209A publication Critical patent/BE888209A/fr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/243Platinum; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
BE0/204323A 1980-03-31 1981-03-31 Solutions concentrees stables de cisplatine dans un solvant BE888209A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US13537380A 1980-03-31 1980-03-31

Publications (1)

Publication Number Publication Date
BE888209A true BE888209A (fr) 1981-09-30

Family

ID=22467813

Family Applications (1)

Application Number Title Priority Date Filing Date
BE0/204323A BE888209A (fr) 1980-03-31 1981-03-31 Solutions concentrees stables de cisplatine dans un solvant

Country Status (30)

Country Link
JP (1) JPS56152415A (fr)
KR (1) KR860000841B1 (fr)
AR (1) AR225500A1 (fr)
AT (1) AT370996B (fr)
AU (1) AU541056B2 (fr)
BE (1) BE888209A (fr)
CA (1) CA1162479A (fr)
CH (1) CH647481A5 (fr)
CS (1) CS246051B2 (fr)
DD (1) DD157762A5 (fr)
DE (1) DE3112272A1 (fr)
DK (1) DK158564C (fr)
ES (1) ES500869A0 (fr)
FI (1) FI70670C (fr)
FR (1) FR2480605A1 (fr)
GB (1) GB2074028B (fr)
GR (1) GR72769B (fr)
HU (1) HU183379B (fr)
IE (1) IE51070B1 (fr)
IL (1) IL62517A (fr)
IT (1) IT1170838B (fr)
LU (1) LU83270A1 (fr)
NL (1) NL8101531A (fr)
NO (1) NO156675C (fr)
NZ (1) NZ196519A (fr)
PH (1) PH17152A (fr)
PT (1) PT72774B (fr)
SE (1) SE455045B (fr)
SU (1) SU1056893A3 (fr)
ZA (1) ZA812084B (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1153974B (it) * 1982-09-23 1987-01-21 Erba Farmitalia Composizioni farmacologiche a base di cisplatino e metodo per il loro ottenimento
NL8303657A (nl) * 1983-10-24 1985-05-17 Pharmachemie Bv Voor injectie geschikte, stabiele, waterige, zoutzuur bevattende oplossing van cisplatine, alsmede werkwijze ter bereiding daarvan.
FI895340A0 (fi) * 1988-11-14 1989-11-09 Bristol Myers Squibb Co Hypertonisk cisplatin-loesning.
AU714992B2 (en) * 1996-08-23 2000-01-13 Alza Corporation Liposomes containing a cisplatin compound
AUPQ641100A0 (en) 2000-03-23 2000-04-15 Australia Nuclear Science & Technology Organisation Methods of synthesis and use of radiolabelled platinum chemotherapeutic ag ents
JP4445304B2 (ja) 2004-03-26 2010-04-07 オンキヨー株式会社 スイッチングアンプ
US8852566B2 (en) * 2009-03-26 2014-10-07 Warsaw Orthopedic, Inc. Compositions and methods for preferential distribution of active agents to injury sites
EP3773498B1 (fr) 2018-03-29 2022-06-22 Project Pharmaceutics GmbH Formulation pharmaceutique liquide

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4177263A (en) * 1972-02-28 1979-12-04 Research Corporation Anti-animal tumor method
SE445172B (sv) * 1978-05-30 1986-06-09 Bristol Myers Co Stabil, steril vattenlosning av cisplatin i enhetsdoseringsform

Also Published As

Publication number Publication date
NZ196519A (en) 1983-06-17
PT72774B (en) 1982-11-16
NL8101531A (nl) 1981-10-16
IL62517A0 (en) 1981-05-20
DK158564B (da) 1990-06-11
DK158564C (da) 1990-11-05
IT8148090A0 (it) 1981-03-24
KR830004849A (ko) 1983-07-20
AU541056B2 (en) 1984-12-13
HU183379B (en) 1984-04-28
GB2074028B (en) 1983-09-21
FR2480605A1 (fr) 1981-10-23
IL62517A (en) 1984-01-31
ES8206545A1 (es) 1982-08-16
IT1170838B (it) 1987-06-03
JPS6360008B2 (fr) 1988-11-22
KR860000841B1 (ko) 1986-07-09
NO156675B (no) 1987-07-27
ZA812084B (en) 1982-04-28
CA1162479A (fr) 1984-02-21
PH17152A (en) 1984-06-13
SE455045B (sv) 1988-06-20
JPS56152415A (en) 1981-11-26
DE3112272C2 (fr) 1990-09-27
GR72769B (fr) 1983-12-02
CS246051B2 (en) 1986-10-16
SU1056893A3 (ru) 1983-11-23
NO156675C (no) 1987-11-04
GB2074028A (en) 1981-10-28
AR225500A1 (es) 1982-03-31
FR2480605B1 (fr) 1984-05-11
ATA150481A (de) 1982-10-15
IE810715L (en) 1981-09-30
DE3112272A1 (de) 1982-04-29
NO811081L (no) 1981-10-01
PT72774A (en) 1981-04-01
AU6816681A (en) 1981-10-08
FI70670B (fi) 1986-06-26
LU83270A1 (fr) 1981-10-29
AT370996B (de) 1983-05-25
DD157762A5 (de) 1982-12-08
CH647481A5 (fr) 1985-01-31
FI810934L (fi) 1981-10-01
ES500869A0 (es) 1982-08-16
DK144281A (da) 1981-10-01
FI70670C (fi) 1986-10-06
IE51070B1 (en) 1986-09-17
SE8101990L (sv) 1981-11-13

Similar Documents

Publication Publication Date Title
BE860976A (fr) Solution stable contenant un acide percarboxylique
IT1116027B (it) Filtro
IT1120374B (it) Cartuccia a spruzzo
DK150634C (da) Filter
DK198279A (da) Dialyseoploesning (2)
DK153649C (da) Udgravningsafstoetningsenhed
NO792135L (no) Transparent vaeskeforbindingsmateriale
NL180159C (nl) Hoogfrequent filter.
ES253924Y (es) Mascarilla filtrante
AT366478B (de) Fluessigkeitspumpe
DK432279A (da) Herbicide forbindelser
PT70561A (de) Schwimmbrettanordnung fur ein windsurfgerat
BE888209A (fr) Solutions concentrees stables de cisplatine dans un solvant
MX143907A (es) Mejoras a pulverizador de liquidos accionado manualmente
MX143902A (es) Mejoras a surtidor de liquidos manualmente operado
IT1113443B (it) Composti erbicidi
FI790845A (fi) Foerfarande och anordning foer att bibehaolla en paosbana aseptisk
ES486624A0 (es) Un compuesto
FI793920A (fi) Foerfarande och anordning foer att jaemnt torka en kontinuerlig bana
ATA438879A (de) Spundfass
FR2431315B1 (fr) Dialyseurs a ecoulements paralleles
IT1165444B (it) Composti contenenti iodio ad azione microbicida
BE872724A (fr) Revolver a triple action
DK464579A (da) Herbicide forbindelser
FI791751A (fi) Globularia-extrakt foerfarande foer dess framstaellning och dess anvaendning i farmacin

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: BRISTOL-MYERS CY

Effective date: 19940331